The Analysis Study Of Type 2 Diabetes Mellitus As Risk Factor For Cardiovascular Disease: A Comprehensive Systematic Review
Keywords:
type 2 diabetes mellitus, risk factors, cardiovascular diseaseAbstract
Background: Diabetes mellitus (DM) is prevalent worldwide and linked to rising cardiovascular morbidity and mortality, increasing healthcare burdens. DM complications include atherosclerosis, ischemic heart disease, and peripheral arterial disease, primarily driven by insulin resistance and hyperglycemia, leading to atherosclerosis progression. This systematic review aims to analyze current evidence on the risk factors influencing cardiovascular disease in diabetes mellitus type 2 patients based on literatures of the last 10 years. Methods: The study adhered to PRISMA 2020 standards, examining English literature from 2014 to 2024. It excluded editorials, reviews from the same journal, and submissions without a DOI. PubMed, SagePub, SpringerLink, and Google Scholar were utilized as literature sources. Result: Initially retrieving 360 articles from online databases (PubMed, SagePub, SpringerLink and Google Scholar) eight relevant papers were selected after three rounds of screening for full-text analysis. Conclusion: This study underline the importance of early intervention, dietary and lifestyle changes, and tailored medication in light of the substantial cardiovascular risks associated with Type 2 Diabetes (T2DM). Reducing risks requires a multimodal strategy that is customized to each patient's unique profile.
References
Fishman SL, Sonmez H, Basman C, Singh V, Poretsky L. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review. Mol Med Camb Mass. 2018;24(1):59. doi:10.1186/s10020-018-0060-3
Marx N, Husain M, Lehrke M, Verma S, Sattar N. GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes. Circulation. 2022;146(24):1882-1894. doi:10.1161/CIRCULATIONAHA.122.059595
Kim SW, Sung IH, Kim YH. Reconstruction of severe atherosclerotic and obstructive diabetic feet using thoracodorsal artery perforator flaps with long vascular pedicles. Microsurgery. 2018;38(3):287-294. doi:10.1002/micr.30251
Katakami N. Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus. J Atheroscler Thromb. 2018;25(1):27-39. doi:10.5551/jat.RV17014
Alman AC, Talton JW, Wadwa RP, et al. Cardiovascular health in adolescents with type 1 diabetes: the SEARCH CVD study. Pediatr Diabetes. 2014;15(7):502-510. doi:10.1111/pedi.12120
Maftei O, Pena AS, Sullivan T, et al. Early atherosclerosis relates to urinary albumin excretion and cardiovascular risk factors in adolescents with type 1 diabetes: Adolescent type 1 Diabetes cardio-renal Intervention Trial (AdDIT). Diabetes Care. 2014;37(11):3069-3075. doi:10.2337/dc14-0700
Haque MJ, Islam MN, Aziz MZA, et al. Association of Cardiovascular Disease with Micro Albuminuria in Type 2 Diabetes Mellitus - Study in A Tertiary Care Hospital. J Med. 2020;21(2):76-81. doi:10.3329/jom.v21i2.50209
Vitale M, Vaccaro O, Masulli M, et al. Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study. Clin Nutr Edinb Scotl. 2017;36(6):1686-1692. doi:10.1016/j.clnu.2016.11.002
Roubille F, Bouabdallaoui N, Kouz S, et al. Low-Dose Colchicine in Patients With Type 2 Diabetes and Recent Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Diabetes Care. 2024;47(3):467-470. doi:10.2337/dc23-1825
Vitale M, Masulli M, Calabrese I, et al. Impact of a Mediterranean Dietary Pattern and Its Components on Cardiovascular Risk Factors, Glucose Control, and Body Weight in People with Type 2 Diabetes: A Real-Life Study. Nutrients. 2018;10(8):1067. doi:10.3390/nu10081067
Magalhães JP, Melo X, Correia IR, et al. Effects of combined training with different intensities on vascular health in patients with type 2 diabetes: a 1-year randomized controlled trial. Cardiovasc Diabetol. 2019;18(1):34. doi:10.1186/s12933-019-0840-2
Walters GWM, Redman E, Gulsin GS, et al. Interrelationship between micronutrients and cardiovascular structure and function in type 2 diabetes. J Nutr Sci. 2021;10:e88. doi:10.1017/jns.2021.82
Goldberg RB, Orchard TJ, Crandall JP, et al. Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study. Circulation. 2022;145(22):1632-1641. doi:10.1161/CIRCULATIONAHA.121.056756
Matsumoto C, Ogawa H, Saito Y, et al. Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus. BMJ Open Diabetes Res Care. 2022;10(2):e002745. doi:10.1136/bmjdrc-2021-002745
Mohan V, Singh AK, Zargar AH, et al. Cardiorenal disease management in type 2 diabetes: An expert consensus. Diabetes Metab Syndr. 2022;16(12):102661. doi:10.1016/j.dsx.2022.102661
Vitale M, Calabrese I, Massimino E, et al. Dietary inflammatory index score, glucose control and cardiovascular risk factors profile in people with type 2 diabetes. Int J Food Sci Nutr. Published online May 19, 2021. Accessed July 4, 2024. https://www.tandfonline.com/doi/abs/10.1080/09637486.2020.1832054
Chu CC, Chen YC, Lin MH, et al. Association between Clinical Use of Colchicine and Risk of Type 2 Diabetes Mellitus among Gouty Patients: A Nationwide Cohort Study. Int J Environ Res Public Health. 2022;19(6):3395. doi:10.3390/ijerph19063395
AlAufi NS, Chan YM, Waly MI, Chin YS, Mohd Yusof BN, Ahmad N. Application of Mediterranean Diet in Cardiovascular Diseases and Type 2 Diabetes Mellitus: Motivations and Challenges. Nutrients. 2022;14(13):2777. doi:10.3390/nu14132777
Becerra-Tomás N, Blanco Mejía S, Viguiliouk E, et al. Mediterranean diet, cardiovascular disease and mortality in diabetes: A systematic review and meta-analysis of prospective cohort studies and randomized clinical trials. Crit Rev Food Sci Nutr. 2020;60(7):1207-1227. doi:10.1080/10408398.2019.1565281
Marcotte-Chénard A, Tremblay D, Mony MM, et al. Low-volume walking HIIT: Efficient strategy to improve physical capacity and reduce the risk of cardiovascular disease in older women with type 2 diabetes. Diabetes Metab Syndr Clin Res Rev. 2021;15(5):102233. doi:10.1016/j.dsx.2021.102233
Way KL, Sabag A, Sultana RN, et al. The effect of low-volume high-intensity interval training on cardiovascular health outcomes in type 2 diabetes: A randomised controlled trial. Int J Cardiol. 2020;320:148-154. doi:10.1016/j.ijcard.2020.06.019
Partula V, Deschasaux M, Druesne-Pecollo N, et al. Associations between consumption of dietary fibers and the risk of cardiovascular diseases, cancers, type 2 diabetes, and mortality in the prospective NutriNet-Santé cohort. Am J Clin Nutr. 2020;112(1):195-207. doi:10.1093/ajcn/nqaa063
Toi PL, Anothaisintawee T, Chaikledkaew U, Briones JR, Reutrakul S, Thakkinstian A. Preventive Role of Diet Interventions and Dietary Factors in Type 2 Diabetes Mellitus: An Umbrella Review. Nutrients. 2020;12(9):2722. doi:10.3390/nu12092722
Zhang K, Yang W, Dai H, Deng Z. Cardiovascular risk following metformin treatment in patients with type 2 diabetes mellitus: Results from meta-analysis. Diabetes Res Clin Pract. 2020;160:108001. doi:10.1016/j.diabres.2020.108001
Li T, Providencia R, Mu N, et al. Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2021;20(1):30. doi:10.1186/s12933-020-01202-5
Geng T, Wang Y, Lu Q, et al. Associations of New-Onset Atrial Fibrillation With Risks of Cardiovascular Disease, Chronic Kidney Disease, and Mortality Among Patients With Type 2 Diabetes. Diabetes Care. 2022;45(10):2422-2429. doi:10.2337/dc22-0717
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Pieters Manaek Tua Bakara (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
